The controversy over the experimental stem cell treatment in India grabbed national headlines last week.
Alberta businessman Lee Chuckry told CBC News in Manitoba that he spent $34,000 for a stem cell therapy in India only to find his MS got worse and that “I think it’s just a big fraudulent scam.” However, another MS patient who took part in the experimental trial claims the treatment helped her.
The controversy points to the need for Canada to make stem cell research and development a national priority. Always a clear leader in stem cell research, Canada needs a coordinated strategy to bring health benefits for Canadians. The goal of the Stem Cell Strategy & Action Plan is for Canada to lead the way in delivering five to 10 safe and effective treatments for chronic diseases within 10 years.
CBC News visited Foundation’s offices in Ottawa to ask President and CEO James Price about the goals of the Strategy. He told the CBC that the Strategy will streamline the process for clinical trials in Canada “so that Canadians that are suffering have access to treatments that are safe and proven to be effective.”